Catalyst Wire Dossier Catalyst Wire Dossier

BSCT

Anti-nf-P2X7 10% ointment · Biosceptre
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BSCT, covering 2016-03-15 to 2016-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment [Phase 1]

See pricing